Analyst Ratings for Champions Oncology (CSBR)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/12/2024 | Craig-Hallum » Updated 3/12/2025 |
Matt G. Hewitt | Upgrade | Buy (Hold) |
12.00 (8.00) |
4.07 (5.87) |
44.23% | Details |
| 3/16/2023 | Benchmark | Robert Wasserman | Downgrade | Hold (Buy) |
N/A (N/A) |
4.10 (5.87) |
43.17% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


